Laurie J. Hall Trustee’s Immunogen Inc IMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-430
Closed -$2K 333
2022
Q4
$2K Sell
430
-245
-36% -$1.33K ﹤0.01% 291
2022
Q3
$3K Sell
675
-305
-31% -$1.61K ﹤0.01% 297
2022
Q2
$4K Hold
980
﹤0.01% 294
2022
Q1
$5K Hold
980
﹤0.01% 301
2021
Q4
$7K Buy
980
+340
+53% +$2.11K ﹤0.01% 290
2021
Q3
$4K Sell
640
-400
-38% -$2.31K ﹤0.01% 310
2021
Q2
$7K Hold
1,040
﹤0.01% 296
2021
Q1
$8K Hold
1,040
﹤0.01% 298
2020
Q4
$7K Hold
1,040
﹤0.01% 296
2020
Q3
$4K Buy
+1,040
New +$4.2K ﹤0.01% 301
2019
Q4
$4K Buy
710
+120
+20% +$407 ﹤0.01% 310
2019
Q3
$1K Hold
590
﹤0.01% 328
2019
Q2
$1K Hold
590
﹤0.01% 331
2019
Q1
$2K Buy
590
+270
+84% +$1.17K ﹤0.01% 327
2018
Q4
$2K Sell
320
-60
-16% -$364 ﹤0.01% 325
2018
Q3
$4K Hold
380
﹤0.01% 336
2018
Q2
$4K Hold
380
﹤0.01% 337
2018
Q1
$4K Hold
380
﹤0.01% 331
2017
Q4
$2K Sell
380
-180
-32% -$1.11K ﹤0.01% 353
2017
Q3
$4.28K Hold
560
﹤0.01% 282
2017
Q2
$3.98K Hold
560
﹤0.01% 286
2017
Q1
$1.89K Hold
560
﹤0.01% 300
2016
Q4
$1K Buy
+560
New +$1.12K ﹤0.01% 295
2016
Q2
$2K Buy
560
+300
+115% +$1.88K ﹤0.01% 294
2016
Q1
$2K Buy
+260
New +$2.2K ﹤0.01% 279

Other funds holding IMGN

Laurie J. Hall Trustee's IMGN Position: Q1 2023 in Review

Laurie J. Hall Trustee sold out of Immunogen Inc (IMGN) in Q1 2023, closing a stake of 430 shares — an estimated $2K sold.

Laurie J. Hall Trustee first reported a position in IMGN in Q1 2016 and held it in 25 quarters. The position peaked at $8K in Q1 2021. 190 funds tracked by Wall St. Rank hold IMGN as of Q1 2023.

  • Laurie J. Hall Trustee reported no remaining Immunogen Inc position as of Q1 2023 after selling out during the quarter.
  • Laurie J. Hall Trustee sold 430 Immunogen Inc shares in Q1 2023, an estimated $2K.
  • Laurie J. Hall Trustee first reported a position in Immunogen Inc in Q1 2016 and held it in 25 quarters.
  • Laurie J. Hall Trustee's Immunogen Inc position peaked at $8K in Q1 2021.
  • 190 funds tracked by Wall St. Rank held Immunogen Inc as of Q1 2023.

Based on Laurie J. Hall Trustee's 13F filing for Q1 2023, filed 7 Apr 2023.